Gujarat Themis Biosyn Intrinsic Value
GUJTHEM Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹125.89 | ₹100.71 - ₹151.07 | -70.0% | EPS: ₹4.40, Sector P/E: 22x |
| Book Value Method | asset | ₹450.91 | ₹405.82 - ₹496.00 | +7.4% | Book Value/Share: ₹225.45, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹287.27 | ₹258.54 - ₹316.00 | -31.5% | Revenue/Share: ₹143.64, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹643.36 | ₹579.02 - ₹707.70 | +53.3% | EBITDA: ₹73.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹1049.12 | ₹839.30 - ₹1258.94 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹125.89 | ₹113.30 - ₹138.48 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹125.89 | ₹113.30 - ₹138.48 | -70.0% | Revenue Growth: 7.3%, Adj P/E: 15.6x |
| ROE Based Valuation | profitability | ₹610.91 | ₹549.82 - ₹672.00 | +45.6% | ROE: 19.4%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹149.40 | ₹134.46 - ₹164.34 | -64.4% | EPS: ₹4.40, BVPS: ₹225.45 |
Want to compare with current market value? Check GUJTHEM share price latest .
Valuation Comparison Chart
GUJTHEM Intrinsic Value Analysis
What is the intrinsic value of GUJTHEM?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Gujarat Themis Biosyn (GUJTHEM) is ₹287.27 (median value). With the current market price of ₹419.65, this represents a -31.5% variance from our estimated fair value.
The valuation range spans from ₹125.89 to ₹1049.12, indicating ₹125.89 - ₹1049.12.
Is GUJTHEM undervalued or overvalued?
Based on our multi-method analysis, Gujarat Themis Biosyn (GUJTHEM) appears to be trading above calculated value by approximately 31.5%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.62 | Industry Standard: 2.0+ | Above 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.21 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 19.4% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 45.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.52x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Gujarat Themis Biosyn
Additional stock information and data for GUJTHEM
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹91 Cr | ₹35 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹64 Cr | ₹37 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹40 Cr | ₹30 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹40 Cr | ₹25 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹11 Cr | ₹10 Cr | Positive Free Cash Flow | 8/10 |